Abstract: A method of treating renal cell carcinoma in a mammal with that disease comprising administering to the mammal a physiologically effective amount of an inhibitor of PDE10.
Type:
Grant
Filed:
May 29, 2002
Date of Patent:
March 25, 2003
Assignee:
Cell Pathways
Inventors:
W. Joseph Thompson, John R. Fetter, Robert E. Bellet, Han Li
Abstract: Benzothienopyrimidine derivatives for inducing or promoting apoptosis and for arresting uncontrolled neoplastic cell proliferation, and specifically for arresting and treating neoplasia, including precancerous and cancerous lesions.